[go: up one dir, main page]

AU2002344208A1 - Molecules for diagnostics and therapeutics - Google Patents

Molecules for diagnostics and therapeutics

Info

Publication number
AU2002344208A1
AU2002344208A1 AU2002344208A AU2002344208A AU2002344208A1 AU 2002344208 A1 AU2002344208 A1 AU 2002344208A1 AU 2002344208 A AU2002344208 A AU 2002344208A AU 2002344208 A AU2002344208 A AU 2002344208A AU 2002344208 A1 AU2002344208 A1 AU 2002344208A1
Authority
AU
Australia
Prior art keywords
therapeutics
diagnostics
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002344208A
Other versions
AU2002344208A8 (en
Inventor
Stefan R. Amshey
Alice J. Chen
Joyce Chinn
Abel Daffo
Christopher R. Dahl
Tam C. Dam
Sean C. Daughtery
Marie H. David
Gerard E. Dufour
Edward Jr. H. Gerstin
Darryl Gietzen
Bernard Harris
Jennifer L. Jackson
Anissa Lee Jones
Yael Kleefeld
Ruth Y. Lan
Samantha A. Lewis
Tommy F. Liu
Audrey Lo
Rakesh Marwaha
Vincent Z. Mullahy-Flores
Duy-Viet An Nguyen
Scott R. Panzer
Careyna H. Peralta
Alanna-Phung B. Tran
Olivia Tuason
Michael E. Urashka
Pierre E. Yap
Jimmy Y. Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002344208A1 publication Critical patent/AU2002344208A1/en
Publication of AU2002344208A8 publication Critical patent/AU2002344208A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002344208A 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics Abandoned AU2002344208A1 (en)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US27961901P 2001-03-28 2001-03-28
US60/279,619 2001-03-28
US28006801P 2001-03-29 2001-03-29
US28006701P 2001-03-29 2001-03-29
US60,280,068 2001-03-29
US60/280,067 2001-03-29
US29128001P 2001-05-16 2001-05-16
US60/291,280 2001-05-16
US29184901P 2001-05-17 2001-05-17
US29182901P 2001-05-17 2001-05-17
US60,291,829 2001-05-17
US60/291,849 2001-05-17
US29942801P 2001-06-19 2001-06-19
US60,299,428 2001-06-19
US30000101P 2001-06-20 2001-06-20
US29977601P 2001-06-20 2001-06-20
US60/299,776 2001-06-20
US60/300,001 2001-06-20
PCT/US2002/010056 WO2002097031A2 (en) 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics

Publications (2)

Publication Number Publication Date
AU2002344208A1 true AU2002344208A1 (en) 2002-12-09
AU2002344208A8 AU2002344208A8 (en) 2005-11-17

Family

ID=27578771

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002344208A Abandoned AU2002344208A1 (en) 2001-03-28 2002-03-27 Molecules for diagnostics and therapeutics
AU2002338265A Abandoned AU2002338265A1 (en) 2001-03-28 2002-03-27 Molecules for disease detection and treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002338265A Abandoned AU2002338265A1 (en) 2001-03-28 2002-03-27 Molecules for disease detection and treatment

Country Status (4)

Country Link
EP (1) EP1383894A2 (en)
AU (2) AU2002344208A1 (en)
CA (2) CA2442705A1 (en)
WO (2) WO2002097031A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
EP1434783A4 (en) * 2001-03-16 2006-06-07 Lilly Co Eli Lp mammalian proteins; related reagents
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
EP1310552B1 (en) 2001-11-09 2007-06-13 Proteologics, Inc. Posh nucleic acids, polypeptides and related methods
US8753822B2 (en) * 2001-12-04 2014-06-17 Wayne State University Neoepitope detection of disease using protein arrays
US8450067B2 (en) * 2002-05-28 2013-05-28 Omrix Biopharmaceuticals Inc. Method for obtaining anti-idiotype antibodies
WO2003104427A2 (en) 2002-06-05 2003-12-18 Case Western Reserve University Methods and compositions for detecting cancers
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
TW200413539A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Genes and polypeptides relating to prostate cancers
AU2003271149A1 (en) * 2002-10-11 2004-05-04 Yamanouchi Pharmaceutical Co., Ltd. Method of screening remedy for renal failure
WO2004047728A2 (en) * 2002-11-26 2004-06-10 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
AU2003296161B2 (en) * 2002-12-27 2009-12-17 National Institute Of Advanced Industrial Science And Technology Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
GB0315827D0 (en) * 2003-07-05 2003-08-13 Imp College Innovations Ltd Methods
WO2005117538A2 (en) * 2004-04-12 2005-12-15 The Trustees Of Columbia University In The City Of New York METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION
EP1627922A1 (en) * 2004-08-18 2006-02-22 Sanofi-Aventis Deutschland GmbH Method of screening for a carnitine transporter agonist or antagonist and its uses
GB0423126D0 (en) * 2004-10-18 2004-11-17 Ares Trading Sa Protein
US7727725B2 (en) 2006-04-27 2010-06-01 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
EP2099491A4 (en) 2006-12-05 2011-06-29 Oncomed Pharm Inc COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER
WO2010053772A2 (en) 2008-10-29 2010-05-14 The Regents Of The University Of California Disease-associated antigens and methods of use thereof
CA2758687A1 (en) 2008-11-14 2010-05-20 Gen-Probe Incorporated Compositions, kits and methods for detection of campylobacter nucleic acid
CN103119054B (en) * 2010-03-26 2017-01-18 达特茅斯大学理事会 VISTA regulatory T cell mediator protein, VISTA binding agent and use thereof
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
SG188497A1 (en) 2010-09-22 2013-05-31 Alios Biopharma Inc Substituted nucleotide analogs
HK1203075A1 (en) 2011-12-22 2015-10-16 艾丽奥斯生物制药有限公司 Substituted phosphorothioate nucleotide analogs
EP2828277A1 (en) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
HK1203356A1 (en) 2012-03-22 2015-10-30 艾丽奥斯生物制药有限公司 Pharmaceutical combinations comprising a thionucleotide analog
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
WO2013192504A1 (en) 2012-06-22 2013-12-27 The Trustees Of Dartmouth College Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders
EP2892558B1 (en) 2012-09-07 2019-04-10 The Trustees Of Dartmouth College Vista modulators for diagnosis and treatment of cancer
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
CN106661107B (en) 2013-12-24 2021-12-24 杨森制药公司 anti-VISTA antibodies and fragments
WO2015191881A2 (en) 2014-06-11 2015-12-17 Green Kathy A Use of vista agonists and antagonists to suppress or enhance humoral immunity
CN107405398A (en) 2014-12-05 2017-11-28 伊穆奈克斯特股份有限公司 VSIG8 is identified as presumption VISTA acceptors and its to produce the purposes of VISTA/VSIG8 activators and antagonist
EP3722314A1 (en) 2015-06-24 2020-10-14 Janssen Pharmaceutica NV Anti-vista antibodies and fragments
EP3413910A1 (en) 2016-02-12 2018-12-19 Janssen Pharmaceutica NV Anti-vista (b7h5) antibodies
IL322448A (en) 2016-04-15 2025-09-01 Immunext Inc Anti-human vista antibodies and use thereof
US12163950B2 (en) * 2018-06-26 2024-12-10 Duke University Synthetic odorant receptors
CN110714017B (en) * 2019-11-06 2023-09-01 河南师范大学 Koi ptps gene, encoded protein and application
CN111621525B (en) * 2020-06-18 2021-04-23 中赛干细胞基因工程有限公司 Application of STX1B gene in promoting growth and differentiation of human adipose-derived mesenchymal stem cells
CN114317732B (en) * 2021-04-08 2023-08-18 博尔诚（北京）科技有限公司 Composition for lung cancer screening and application thereof

Also Published As

Publication number Publication date
WO2002079449A2 (en) 2002-10-10
WO2002097031A2 (en) 2002-12-05
CA2447183A1 (en) 2002-10-10
AU2002344208A8 (en) 2005-11-17
CA2442705A1 (en) 2002-12-05
AU2002338265A1 (en) 2002-10-15
WO2002079449A3 (en) 2003-03-20
EP1383894A2 (en) 2004-01-28
WO2002097031A3 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
AU2002344208A1 (en) Molecules for diagnostics and therapeutics
AU2003289716A1 (en) Molecules for diagnostics and therapeutics
AU2002353725A1 (en) Super-austenitic stainless steel
EP1271099A3 (en) Method and arrangement for determining movement
AU2002351212A1 (en) Uri munging
AU2002325755A1 (en) Methods and apparatuses for purification
AUPR851701A0 (en) Seating apparatus
WO2003040317A8 (en) Lung cancer therapeutics and diagnostics
AU2002245332A1 (en) Anergy-regulated molecules
AU2002337312A1 (en) Molecules
AU2002364007A1 (en) Systems and methods for evaluating opportunities
AU2002359694A1 (en) Compounds and methods
AU2003210518A1 (en) Molecules for diagnostics and therapeutics
AU2002307031A1 (en) Thrombospondin-2 and uses thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2002366128A1 (en) Quality factor
AU2002252459A1 (en) Customized therapeutics and in situ diagnostics
AU2002305913A1 (en) Molecules for diagnostics and therapeutics
AU4018201A (en) Molecules for diagnostics and therapeutics
AU2002334632A1 (en) Lipid-associated molecules
AU2001286964A1 (en) Molecules for diagnostics and therapeutics
AU2001241754A1 (en) Molecules for diagnostics and therapeutics
AU2002309917A1 (en) Lipid-associated molecules
AU5320900A (en) Molecules for diagnostics and therapeutics
AU2002222554A1 (en) Clear tooth sample and process for producing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase